Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432648 · ClinicalTrials.gov registry record · NA
Fiber Food Introduction in Pediatric Short Bowel Syndrome
A NA study of Short Gut Syndrome, sponsored by Children's Hospital of Philadelphia.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05432648: Active NA study of Short Gut Syndrome, sponsored by Children's Hospital of Philadelphia.
NCT05432648 is a NA study of Short Gut Syndrome that is active but no longer recruiting, run by Children's Hospital of Philadelphia. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432648, a NA study of Short Gut Syndrome, is active but no longer recruiting, sponsored by Children's Hospital of Philadelphia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Short bowel syndrome (SBS) is a rare but challenging condition in which patients have insufficient bowel length to meet fluid, electrolyte, and nutrient requirements without parenteral support. The purpose of this study is to determine how well dietary fiber is tolerated in patients with short bowel syndrome compared to patients without short bowel syndrome based on assessment of gastrointestinal symptoms, and corresponding changes in microbiome composition and metabolomics.
Primary Outcome
To assess the rate of continuation and symptoms/signs leading to discontinuation of fiber addition in SBS vs controls
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Green bean puree
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-05-08 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT05432648 still lists
NCT05432648 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Short Gut Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Green bean puree is the first listed.
NCT05432648 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05432648 about?
NCT05432648 is a clinical study titled "Fiber Food Introduction in Pediatric Short Bowel Syndrome". Short bowel syndrome (SBS) is a rare but challenging condition in which patients have insufficient bowel length to meet fluid, electrolyte, and nutrient requirements without parenteral support. The purpose of this study is to determine how well dietary fiber is tolerated in patients with short bowe...
What is the current status of trial NCT05432648?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-05-08. Estimated completion is 2026-05.
What conditions does trial NCT05432648 study?
This clinical trial studies the following conditions: Short Gut Syndrome.
What interventions are being tested in trial NCT05432648?
The interventions under investigation include: Green bean puree (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05432648?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432648 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05432648's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI